Autopsy report · NCT03644706

Study Evaluating Subjects With Distal Renal Tubular Acidosis

“COVID-19 pandemic negatively impacted the ability to enroll patients.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 1 month before it started.
• Ran for about 2 years 3 months before it stopped.
• 3 participants enrolled.
• Results were posted on the registry 2 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Advicenne Pharma

Sponsor type

Industry

Conditions

Distal Renal Tubular Acidosis

Interventions

ADV7103; Placebo

Participants

3

Sites

8

Countries

Canada, United States

Trials that died the same way

• Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases
  “Enrollment was affected due to the COVID-19 pandemic” (77% match in meaning)
• Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate
  “Covid 19 Pandemic - Unable to enroll patients” (76% match in meaning)
• Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation
  “COVID-19 pandemic adversely affected recruitment.” (73% match in meaning)
• Changing Developmental Trajectories Through Early Treatment
  “Participant enrollment was hindered by the COVID-19 pandemic and the study was ultimately terminated.” (73% match in meaning)
• Measures to Improve Outcomes After an Opioid Overdose
  “COVID-19 pandemic interfered with ability to conduct study.” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.